SCHEMBL3046995

SCHEMBL3046995

O=C1NC(=O)c2c1cccc2-c1cc2ccccc2s1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 1/20 0.47
CREBBP Q92793 1/20 0.47
APP P05067 2/20 0.44
PARP1 P09874 1/20 0.43
CA1 P00915 2/20 0.42
CA9 Q16790 2/20 0.42
CA2 P00918 1/20 0.42
GSK3B P49841 3/20 0.41
PRKDC P78527 3/20 0.40
PTP4A3 O75365 2/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
ERN1 O75460 1/20 0.40
PIK3CD O00329 1/20 0.40
PIK3CA P42336 1/20 0.40
NQO1 P15559 1/20 0.39
NQO2 P16083 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTP4A2 Q12974 1/20 0.38
PTP4A1 Q93096 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19133572 0.76 APP (0.57) BRD4CREBBPAPPCA1CA9
SCHEMBL12854022 0.74 APP (0.55) BRD4CREBBPAPPCA1CA9
SCHEMBL2586686 0.73 APP (0.51) BRD4CREBBPAPPCA1CA9
SCHEMBL27989389 0.72 APP (0.57) APPCA1CA9CA2HSD17B1
SCHEMBL16754925 0.72 GSK3B (0.62) PARP1GSK3BNPSR1GAARXFP1
SCHEMBL31070704 0.72 NQO1 (0.54) BRD4CREBBPAPPCA1CA9
SCHEMBL12405297 0.72 APP (0.53) BRD4CREBBPAPPCA1CA9
SCHEMBL5359116 0.72 APP (0.49) BRD4CREBBPAPPCA1CA9
SCHEMBL4868139 0.72 NQO1 (0.54) BRD4CREBBPAPPCA1CA9
SCHEMBL31345019 0.72 RAB9A (0.53) NPSR1GAACYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745641-B2 Nitrogen-containing heterocyclic compound KYOWA HAKKO KIRIN CO., LTD. (JP) 2010-06-29 US disclosed
EP-2108642-A1 JAK INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2009-10-14 EP disclosed
US-20090054407-A1 Nitrogen-containing heterocyclic compound KYOWA HAKKO KOGYO CO., LTD. (JP) 2009-02-26 US disclosed
EP-1880993-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUND KYOWA HAKKO KOGYO CO., LTD. (JP) 2008-01-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054407-A1 Nitrogen-containing heterocyclic compound NR4A1, NR5A2, PRMT8 BRD4 47/4885CREBBP 904/4885APP 3556/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.